4 Tri Harbor Court
United States - Map
Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products, and specialty chemicals. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and bio chemicals used in pharmaceutical and nutritional preparations. It markets and distributes its generic prescription and over the counter pharmaceutical products to wholesalers, chain drug stores, distributors, mass market merchandisers, and others. The Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates to various generic drug companies. The Performance Chemicals segment provides specialty chemicals, such as antioxidants, photo initiators, catalysts, curatives, brighteners, and adhesion promoters, which make plastics, surface coatings, textiles, fuels, and lubricants; diazos and couplers used in microfilms and blueprints, as well as in the photo tooling of printed circuit boards; and organic intermediates and colorants. Its raw materials are also used in electronic parts and binders. This segment also offers agricultural protection products comprising herbicides, fungicides, and insecticides, which control weed growth and the spread of insects and microorganisms; and sprout inhibitors for potatoes. The company serves various companies in the industrial chemical, agricultural, and human health and pharmaceutical industries primarily in the United States, Europe, and Asia. Aceto Corporation was founded in 1947 and is headquartered in Port Washington, New York.
|Aceto Corp.’s ISS Governance QuickScore as of Jul 1, 2014 is 3. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 4; Compensation: 4.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Salvatore J. Guccione ,
Chief Exec. Officer, Pres and Director
|Mr. Douglas Roth ,
Chief Financial Officer, Principal Accounting Officer, Chief Admin. Officer, Sr. VP, Treasurer and Assistant Sec.
|Mr. Frank DeBenedittis ,
Sr. VP of Corp. Bus. Devel. and International Sr. VP of Active Pharmaceutical Ingredients
|Mr. David B. Rosen ,
Sr. VP of Bus. Devel.
|Mr. Theodore S. Ayvas ,
Director of Corp. Communications & Investor Relations
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|